3 Amendments of Franziska Katharina BRANTNER related to 2011/0401(COD)
Amendment 40 #
Proposal for a regulation
Article 16 – paragraph 2 a (new)
Article 16 – paragraph 2 a (new)
2a. All calls for proposals in the area of security research shall be subject to an ethical and societal ex-ante impact assessment and all projects proposed for financing subject to an ethical review during implementation. The ex-ante impact assessment and the review shall extend beyond the narrow confines of privacy and data protection and take into account the broader societal impacts of the underlying security R&D agenda. Calls and project proposals that raise substantial ethical and/or societal impact concerns shall be subject to enhanced scrutiny and control.
Amendment 41 #
Proposal for a regulation
Article 21 – paragraph 2 – subparagraph 1
Article 21 – paragraph 2 – subparagraph 1
Targeted actions with the objective of promoting cooperation with specific third countries or groups of third countries shall be implemented on the basis of common interest and mutual benefit, taking into account their scientific and technological capabilities and market opportunities, and the expected impact. These actions shall include, in particular, research capacity building in developing countries and cooperation projects focusing on developing countries' specific needs in areas such as health – including research on neglected diseases – agriculture, fisheries and the environment, and implemented with financial conditions adapted to their capacities.
Amendment 45 #
Proposal for a regulation
Annex 1 – section 3 – point 1 – point 1.2 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.2 – paragraph 1
Disease and disability are not stopped by national borders. An appropriate European level research and innovation response in partnership with third countries can and should make a crucial contribution to addressing these global challenges, thereby working to achieve the Millennium Development Goals, deliver better health and wellbeing for all, and position Europe as a leader in the rapidly expanding global markets for health and wellbeing innovations.